VWA
ABMD

V Wealth Advisors’s Abiomed Inc ABMD Stock Holding History

V Wealth Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,680
Closed -$556K – 479
2022
Q1 		$556K Sell
1,680
-330
-16% -$102K 0.09% 226
2021
Q4 		$722K Sell
2,010
-445
-18% -$150K 0.11% 188
2021
Q3 		$799K Buy
2,455
+605
+33% +$205K 0.12% 176
2021
Q2 		$577K Buy
+1,850
New +$568K 0.09% 243

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

V Wealth Advisors's ABMD Position: Q2 2022 in Review

V Wealth Advisors sold out of Abiomed Inc (ABMD) in Q2 2022, closing a stake of 1,680 shares — an estimated $556K sold.

V Wealth Advisors first reported a position in ABMD in Q2 2021 and held it in 4 quarters. The position peaked at $799K in Q3 2021. 496 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.

  • V Wealth Advisors reported no remaining Abiomed Inc position as of Q2 2022 after selling out during the quarter.
  • V Wealth Advisors sold 1,680 Abiomed Inc shares in Q2 2022, an estimated $556K.
  • V Wealth Advisors first reported a position in Abiomed Inc in Q2 2021 and held it in 4 quarters.
  • V Wealth Advisors's Abiomed Inc position peaked at $799K in Q3 2021.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.

Based on V Wealth Advisors's 13F filing for Q2 2022, filed 27 Jul 2022.